
Adam Steinlauf
@Adams1002
Followers
615
Following
528
Media
151
Statuses
714
I am a specialist in the Inflammatory Bowel Diseases (IBD), Ulcerative Coltitis and Crohn's Disease @ Mount Sinai
New York City
Joined August 2010
Great evening with colleagues and fellows!!.
Springtime at @MountSinaiGI means another round of Faculty Dining Series! (No bowel prep required.) . @Danny_WongMD @Typical_Brian @RababOun @HyderSaidMD @Adams1002 @ManasiAgrawalMD @brownbrij76 @jdclaytor @SalamBeahMD @JellyanaPeraza
1
0
5
Our article on biosimilars for the ACG FDA-Related Matters Committee.
In the 📕#RedJournal:. Overview of Biosimilars in Inflammatory Bowel Diseases.Feagins, et al. 👉 @GimdGold @Adams1002
0
4
6
RT @AmJGastro: In the 📕#RedJournal:. Overview of Biosimilars in Inflammatory Bowel Diseases.Feagins, et al. 👉 @Gi….
0
7
0
RT @MSHS_IBDCenter: If you suffer from IBD and your disease is difficult to control, or if you simply want to be involved in research that….
0
2
0
RT @MSHS_IBDCenter: Are you interested in participating in a clinical trial for Inflammatory Bowel Disease? If so, please fill out the foll….
0
2
0
RT @IcahnMountSinai: Dr. Marla Dubinsky discusses a study that showed the efficacy of Mirikizumab in patients with ulcerative colitis, high….
0
4
0
RT @DOMSinaiNYC: Congratulations to Adam Steinlauf, MD, for receiving the prestigious 2023 Rosenthal Humanitarian of the Year Award from th….
0
2
0
Our review article for the @AmCollegeGastro FDA-related Matters Committee. Overview of biosimilars in inflammatory bowel diseases : Official journal of the American College of Gastroenterology | ACG
0
5
18
RT @MountSinaiGI: As we wrap up a day filled with revealing talks and diverse viewpoints on #IBD, at the center of every discussion was one….
0
2
0